Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG Oncology making new highs

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Feb 17, 2024 7:09pm

290 Views

Post# 35886217

RE:RE:CG Oncology making new highs

HC Wainwright gives CGON a $75 dollar SP target. That's $4.5 Billion US not fully diluted! All they have is Bladder cancer on the pipeline. That would be $6 Billion plus CAN . If we had a similar target that would be $20 per share CAN fully diluted. https://www.marketbeat.com/instant-alerts/nasdaq-cgon-initiated-coverage-2024-02-14/

enriquesuave wrote:
$3Billion US is $4Billion CAD. So if we were trading at same MC we would be at $12 -13 per share fully diluted. Can we just go up to half on BTD? Would be awesome!

livermore2 wrote: Over $3B valuation at $50usd share price. I see CGON as a near valuation peer to TLT should we be successful in BTD.

Good luck